Unresectable Pancreatic Cancer Clinical Trials

7 recruiting

Unresectable Pancreatic Cancer Trials at a Glance

7 actively recruiting trials for unresectable pancreatic cancer are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Chongqing, Goyang-si, and Holon. Lead sponsors running unresectable pancreatic cancer studies include Alpha Tau Medical LTD., Chengdu New Radiomedicine Technology Co. LTD., and Dana-Farber Cancer Institute.

Browse unresectable pancreatic cancer trials by phase

Treatments under study

About Unresectable Pancreatic Cancer Clinical Trials

Looking for clinical trials for Unresectable Pancreatic Cancer? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Unresectable Pancreatic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Unresectable Pancreatic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

Pancreatic CancerPancreatic AdenocarcinomaUnresectable Pancreatic Cancer
Alpha Tau Medical LTD.15 enrolled1 locationNCT06026943
Recruiting
Not Applicable

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma+1 more
Alpha Tau Medical LTD.15 enrolled2 locationsNCT05657743
Recruiting
Early Phase 1

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer

Unresectable Pancreatic Cancer
The First Affiliated Hospital of Air Force Medicial University3 enrolled1 locationNCT07198659
Recruiting
Phase 2

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Unresectable Pancreatic CancerUnresectable Bile Duct CarcinomaUnresectable Biliary Tract Carcinoma
National Cancer Center, Korea98 enrolled1 locationNCT06135896
Recruiting
Phase 4

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Unresectable Pancreatic Cancer
Hospital Clinico Universitario de Santiago100 enrolled4 locationsNCT06099119
Recruiting
Phase 1Phase 2

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute100 enrolled2 locationsNCT04789486
Recruiting
Phase 1

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)

Unresectable Pancreatic Cancer
Chengdu New Radiomedicine Technology Co. LTD.58 enrolled6 locationsNCT06278454